7-150951562-A-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_000238.4(KCNH2):c.1831T>A(p.Tyr611Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 14/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y611D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | MANE Select | c.1831T>A | p.Tyr611Asn | missense | Exon 7 of 15 | NP_000229.1 | ||
| KCNH2 | NM_001406753.1 | c.1543T>A | p.Tyr515Asn | missense | Exon 5 of 13 | NP_001393682.1 | |||
| KCNH2 | NM_172056.3 | c.1831T>A | p.Tyr611Asn | missense | Exon 7 of 9 | NP_742053.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | TSL:1 MANE Select | c.1831T>A | p.Tyr611Asn | missense | Exon 7 of 15 | ENSP00000262186.5 | ||
| KCNH2 | ENST00000330883.9 | TSL:1 | c.811T>A | p.Tyr271Asn | missense | Exon 3 of 11 | ENSP00000328531.4 | ||
| KCNH2 | ENST00000461280.2 | TSL:1 | n.1129T>A | non_coding_transcript_exon | Exon 3 of 5 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
The p.Y611N variant (also known as c.1831T>A), located in coding exon 7 of the KCNH2 gene, results from a T to A substitution at nucleotide position 1831. The tyrosine at codon 611 is replaced by asparagine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. A likely pathogenic variant, p.Y611H, has been described in the same codon in individuals with long QT syndrome (Tanaka T et al. Circulation, 1997 Feb;95:565-7; Larsen LA et al. Hum. Mutat., 2001 Nov;18:451-7). Based on available evidence to date, the clinical significance of the p.Y611N alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at